FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070048719> ?p ?o ?g. }

• W2070048719 endingPage "1124" @default.
• W2070048719 startingPage "1115" @default.
• W2070048719 abstract "A HeLa T4 cell line containing a defective human immunodeficiency virus type 1 (HIV-1) DNA (HD4) was isolated. After transactivation with Tat, the HD4 DNA was transcribed into a single 3.7-kb mRNA that encodes a chimeric CD4/Env protein and a multitarget-ribozyme directed against multiple sites within the gp120 coding region of HIV-1 RNA (Chen et al., 1992). Early steps in HIV infection such as entry, reverse transcription, and proviral DNA formation were not affected in HD4 cells, and HD4 was efficiently transactivated after either HIV-1 or HIV-2 infections. HIV-2, which lacks all of the HIV-1-specific ribozyme target sites, replicated to high levels in HD4 cells whereas HIV-1 replication was selectively inhibited. Despite a reduced accumulation of all HIV-1 transcripts, transactivation of HD4 was efficient. Surprisingly, the most abundant, multiply spliced mRNAs were reduced even though they lack all of the ribozyme target sites. These results strongly suggest that the ribozyme co-localizes with unspliced HIV-1 pre-mRNA and/or genomic HIV-1 RNA in the nucleus. Cleavage of these precursor RNAs explains the reduction of all spliced and unspliced HIV-1 RNAs. Cleavage of genomic RNA probably contributed to the three-fold reduction in the infectivity of viral progeny. Thus, the HD4 ribozyme RNA functioned as a ribozyme in the nucleus and as a mRNA for a chimeric CD4/Env protein in the cytoplasm. Its unusual large size for a ribozyme (3.7 kb) indicates that, in the future, other antiviral proteins, like negative transdominant mutant HIV-1 proteins, may also be encoded to increase its antiviral potential in a gene therapy approach. Combination therapies against human immunodeficiency virus type 1 (HIV-1) carry the most promise for long-term protection. Protecting HIV-1 target cells against viral pathogenesis and reducing the viral load may help delay the onset of acquired immunodeficiency syndrome (AIDS). Gene therapy against HIV-1 could be part of such combination therapies. For this purpose, we have inserted a multitarget-ribozyme into a defective HIV-1 proviral DNA under transcriptional control of HIV-1 Tat. Upon challenge with HIV-1, the efficacy of this ribozyme transcript with respect to the inhibition of viral replication was evaluated as well as the mechanism and the cellular location of ribozyme activity. Our results indicate that ribozyme RNA was functional in the nucleus and could encode an additional antiviral protein. We conclude that a gene therapy using a defective HIV-1 provirus of this type when efficiently delivered to hematopoietic progenitor cells may enhance the efficacy of a combination therapy against HIV-1." @default.
• W2070048719 created "2016-06-24" @default.
• W2070048719 creator A5019916245 @default.
• W2070048719 creator A5027413431 @default.
• W2070048719 creator A5031657561 @default.
• W2070048719 creator A5051602075 @default.
• W2070048719 creator A5058547446 @default.
• W2070048719 creator A5062092073 @default.
• W2070048719 date "1997-06-10" @default.
• W2070048719 modified "2023-09-25" @default.
• W2070048719 title "Defective HIV-1 Provirus Encoding a Multitarget-Ribozyme Inhibits Accumulation of Spliced and Unspliced HIV-1 mRNAs, Reduces Infectivity of Viral Progeny, and Protects the Cells from Pathogenesis" @default.
• W2070048719 cites W1480555318 @default.
• W2070048719 cites W1482357660 @default.
• W2070048719 cites W1504625876 @default.
• W2070048719 cites W1524845305 @default.
• W2070048719 cites W1524880457 @default.
• W2070048719 cites W1528370780 @default.
• W2070048719 cites W1533636341 @default.
• W2070048719 cites W1556458994 @default.
• W2070048719 cites W1566859727 @default.
• W2070048719 cites W1570375907 @default.
• W2070048719 cites W1659719610 @default.
• W2070048719 cites W1770111419 @default.
• W2070048719 cites W1964916693 @default.
• W2070048719 cites W1971193115 @default.
• W2070048719 cites W1977453669 @default.
• W2070048719 cites W2004890980 @default.
• W2070048719 cites W2011187106 @default.
• W2070048719 cites W2018643676 @default.
• W2070048719 cites W2030259380 @default.
• W2070048719 cites W2033282111 @default.
• W2070048719 cites W2045224288 @default.
• W2070048719 cites W2047908387 @default.
• W2070048719 cites W2050992506 @default.
• W2070048719 cites W2051585221 @default.
• W2070048719 cites W2064007795 @default.
• W2070048719 cites W2071601231 @default.
• W2070048719 cites W2076268959 @default.
• W2070048719 cites W2083502546 @default.
• W2070048719 cites W2104148336 @default.
• W2070048719 cites W2118026266 @default.
• W2070048719 cites W2128398347 @default.
• W2070048719 cites W2128743076 @default.
• W2070048719 cites W2160144091 @default.
• W2070048719 cites W2168554176 @default.
• W2070048719 cites W2335077890 @default.
• W2070048719 doi "https://doi.org/10.1089/hum.1997.8.9-1115" @default.
• W2070048719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9189769" @default.
• W2070048719 hasPublicationYear "1997" @default.
• W2070048719 type Work @default.
• W2070048719 sameAs 2070048719 @default.
• W2070048719 citedByCount "27" @default.
• W2070048719 countsByYear W20700487192013 @default.
• W2070048719 countsByYear W20700487192014 @default.
• W2070048719 countsByYear W20700487192015 @default.
• W2070048719 crossrefType "journal-article" @default.
• W2070048719 hasAuthorship W2070048719A5019916245 @default.
• W2070048719 hasAuthorship W2070048719A5027413431 @default.
• W2070048719 hasAuthorship W2070048719A5031657561 @default.
• W2070048719 hasAuthorship W2070048719A5051602075 @default.
• W2070048719 hasAuthorship W2070048719A5058547446 @default.
• W2070048719 hasAuthorship W2070048719A5062092073 @default.
• W2070048719 hasConcept C104317684 @default.
• W2070048719 hasConcept C1292079 @default.
• W2070048719 hasConcept C150194340 @default.
• W2070048719 hasConcept C153911025 @default.
• W2070048719 hasConcept C159047783 @default.
• W2070048719 hasConcept C2779792011 @default.
• W2070048719 hasConcept C30951146 @default.
• W2070048719 hasConcept C54355233 @default.
• W2070048719 hasConcept C54458228 @default.
• W2070048719 hasConcept C67705224 @default.
• W2070048719 hasConcept C76346623 @default.
• W2070048719 hasConcept C86803240 @default.
• W2070048719 hasConceptScore W2070048719C104317684 @default.
• W2070048719 hasConceptScore W2070048719C1292079 @default.
• W2070048719 hasConceptScore W2070048719C150194340 @default.
• W2070048719 hasConceptScore W2070048719C153911025 @default.
• W2070048719 hasConceptScore W2070048719C159047783 @default.
• W2070048719 hasConceptScore W2070048719C2779792011 @default.
• W2070048719 hasConceptScore W2070048719C30951146 @default.
• W2070048719 hasConceptScore W2070048719C54355233 @default.
• W2070048719 hasConceptScore W2070048719C54458228 @default.
• W2070048719 hasConceptScore W2070048719C67705224 @default.
• W2070048719 hasConceptScore W2070048719C76346623 @default.
• W2070048719 hasConceptScore W2070048719C86803240 @default.
• W2070048719 hasIssue "9" @default.
• W2070048719 hasLocation W20700487191 @default.
• W2070048719 hasLocation W20700487192 @default.
• W2070048719 hasOpenAccess W2070048719 @default.
• W2070048719 hasPrimaryLocation W20700487191 @default.
• W2070048719 hasRelatedWork W1527255489 @default.
• W2070048719 hasRelatedWork W2001396871 @default.
• W2070048719 hasRelatedWork W2002484773 @default.
• W2070048719 hasRelatedWork W2006162544 @default.
• W2070048719 hasRelatedWork W2063581532 @default.
• W2070048719 hasRelatedWork W2089580514 @default.
• W2070048719 hasRelatedWork W2090692139 @default.

• next